Atlas Trials

Study of Opebacan in Patients Undergoing Myeloablative Allogeneic Hematopoietic Stem Cell Transplantation (HSCT)

Clinical trial NCT00454155 · TERMINATED

Trial details

NCT number
NCT00454155
Sponsor
XOMA (US) LLC
Status
TERMINATED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Graft Versus Host Disease
Start date
2007-02-01
Primary completion
2010-06-01
Enrollment
6

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.